Andere Sprachen Eton Pharmaceuticals, Inc.

Aktien

A2N38G

US29772L1089

ETON

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:01 03.05.2024			% 5 Tage	% 1. Jan.
3.71 ^USD	-1.07%		+7.54%	-15.30%

30.04.	Sektor-Update: Aktien des Gesundheitswesens legen im Nachmittagshandel zu	MT
30.04.	Eton Pharmaceuticals reicht bei der FDA einen neuen Zulassungsantrag für ET-400 ein	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference	01.05.
Sector Update: Health Care Stocks Gain in Afternoon Trading	30.04.
Eton Pharmaceuticals Submits New Drug Application to FDA For ET-400	30.04.
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)	30.04.
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)	30.04.
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)	30.04.
Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024	29.04.
Eton Pharmaceuticals, Inc. cancelled the transaction announced on April 15, 2024	17.04.
Eton Pharmaceuticals, Inc. announced that it expects to receive $13.125 million in funding	15.04.
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE	25.03.
Bourse Zurich: en rouge pour finir la semaine "banques centrales"	22.03.
Sector Update: Health Care Stocks Steady Pre-Bell Friday	22.03.
Sector Update: Health Care	22.03.
Eton Pharmaceuticals Acquires U.S. Rights to PKU GOLIKE from Relief Therapeutics Holding SA	22.03.
Eton Pharmaceuticals Acquires US Rights to Phenylketonuria Dietary Management Product	22.03.
Relief Therapeutics trouve un partenaire de distribution US pour le Golike	22.03.
Relief Therapeutics Grants Eton Pharmaceuticals Exclusive License for US Commercialization of Golike	22.03.
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria	22.03.
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria	22.03.
Eton Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Eton Pharmaceuticals, Inc.

Aktien

A2N38G

US29772L1089

ETON

Andere Sprachen

Filter